KRAS mutation in patients undergoing hepatic resection for colorectal liver metastasis: A biomarker of cancer biology or a byproduct of patient selection?
dc.contributor.author | Søreide, Kjetil | en_US |
dc.contributor.author | Sandvik, Odd Mathias | en_US |
dc.contributor.author | Søreide, Jon Arne | en_US |
dc.date.accessioned | 2015-10-16T11:37:20Z | |
dc.date.available | 2015-10-16T11:37:20Z | |
dc.date.issued | 2014-12 | |
dc.identifier.issn | 0008-543X | |
dc.identifier.uri | https://hdl.handle.net/1956/10583 | |
dc.language.iso | eng | eng |
dc.publisher | Wiley | eng |
dc.rights | Attribution CC BY-NC-ND | eng |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/ | eng |
dc.title | KRAS mutation in patients undergoing hepatic resection for colorectal liver metastasis: A biomarker of cancer biology or a byproduct of patient selection? | en_US |
dc.type | Journal article | |
dc.description.version | publishedVersion | en_US |
dc.rights.holder | Copyright 2014 The Authors | |
dc.identifier.doi | https://doi.org/10.1002/cncr.28979 | |
dc.source.journal | Cancer | |
dc.source.40 | 120 | |
dc.source.14 | 24 | |
dc.source.pagenumber | 3862-3865 |